We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

INGN:NASDAQInogen, Inc Analysis

Data as of 2026-04-10 - not real-time

$6.45

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Inogen, Inc. shows a mixed picture. Technically the stock is perched just above its short‑term moving average and below its longer‑term average, while the relative strength index sits near the midpoint, suggesting neither extreme overbought nor oversold conditions. The MACD histogram is positive and the signal line is bullish, reinforced by an increasing volume trend, which together point to modest upside momentum toward the identified resistance zone.
Fundamentally, the company reports negative margins, a negative cash‑flow profile and a forward price‑to‑earnings ratio that is deeply negative, indicating earnings pressure. However, the price‑to‑book ratio is below one and the upside‑downside metric signals a sizable upside potential, aligning with the analyst consensus of a strong‑buy stance.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Bullish MACD and rising volume
  • Price holding above support level
  • Analyst consensus of strong buy

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Potential revenue growth from portable oxygen market
  • Improving valuation metrics relative to book
  • Strategic board appointment indicating governance strength

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained cash‑flow deficits and negative margins
  • Regulatory and reimbursement uncertainties in medical devices
  • Long‑term demand for home respiratory solutions

Key Metrics & Analysis

Financial Health

Revenue Growth2.00%
Profit Margin-6.52%
P/E Ratio-20.8
ROE-12.43%
ROA-6.35%
Debt/Equity9.09
P/B Ratio0.9
Op. Cash Flow$-11216000
Free Cash Flow$-21157376
Industry P/E26.0

Technical Analysis

TrendNeutral
RSI53.5
Support$5.86
Resistance$7.00
MA 20$6.32
MA 50$6.12
MA 200$7.04
MACDBullish
VolumeIncreasing
Fear & Greed Index86.21

Valuation

Target Price$12.67
Upside/Downside96.38%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.10
Volatility41.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.